Navigation Links
Oridion Announces Significant Medical Research to be Presented at AARC Congress
Date:12/10/2008

JERUSALEM and NEEDHAM, Massachusetts, December 10 /PRNewswire-FirstCall/ -- Oridion Systems Ltd. (SIX Swiss Exchange: ORIDN) today announced that three substantial medical research project findings will be presented at the upcoming AARC (American Association for Respiratory Care) Congress in Anaheim, California. These studies confirm the clinical benefits of End-tidal CO2 (EtCO2) monitoring using Oridion Microstream(R) capnography technology and clearly show that capnography needs to be included in a hospital's respiratory monitoring strategy.

Proprietary EtCO2 monitoring solutions from Oridion can increase patient safety and improve patient outcomes utilizing information from the patient's respiratory system. Oridion has focused on providing a technology that provides the clinician with a simple and accurate assessment of a patient's ventilatory status which can provide an early prediction of events. A short summary of the studies from ASA and AARC are discussed below.

An Israel Institute of Technology - Technion study concluded that EtCO2 measurement contributes significantly to the prediction of events during pediatric and adult endoscopy procedures under general anesthesia and conscious sedation.

Two research studies, completed in cooperation between The Brigham and Women's Hospital (Boston, MA) and The University of Alabama in Birmingham, investigated the use of Oridion Microstream Technology and the Smart CapnoLine(R) H Plus CO2 sampling line during the administration of supplemental oxygen delivered by a wide range of oxygen masks. These masks blow oxygen enriched breathing gas toward the patient's nose and mouth. Patients receiving oxygen are at risk for breathing difficulty which can be best monitored by measuring ventilation, which is measured by capnography. In these studies, the Oridion products revealed no significant difference in EtCO2 or respiratory rate when the test subjects were breathing with and without the oxygen masks for all masks and oxygen concentrations tested. The researchers believe that this will aid patient monitoring in clinical practice.

The above medical research projects join four additional papers that were presented in October 2008 at the ASA (American Society of Anesthesiologists) Annual Meeting in Orlando, Florida. Among the studies released was a comprehensive research paper focused on Oridion's latest major initiative "IPI* - Integrated Pulmonary Index" conducted by physician/scientists from Medical College of Georgia in Augusta. IPI helps caregivers manage four complicated monitoring parameters with a single, simplified number. IPI utilizes End-tidal CO2, respiration rate, heart rate and SpO2 to provide an uncomplicated, inclusive assessment of a patient's ventilatory status.

Additional papers presented at ASA included a study from the Brigham & Women's Hospital in Boston showing that CO2 measurement using the Oridion CapnoBloc(TM) is an effective and accurate sampling method during upper gastrointestinal endoscopy. Another important study concluded that expert medical education and training can improve patient safety.

Furthermore, a study published in this month's issue of PEDIATRICS - The Official Journal of the American Academy of Pediatrics concluded that Microstream(R) capnography with its low flow rate made non-invasive capnography possible in the NICU. The study also showed that ETCO2, measured by Microstream(R) capnography has good correlation with PACO2, and is reliable in severe lung disease.

A full list of the medical publications can be found on the Oridion Website http://www.oridion.com/global/english/clinical_solutions/overview/ research.html

(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

Oridion is the global leader of innovative capnography monitoring solutions helping to improve patient safety, and its Microstream(R) capnography technology has become the standard of care in ventilation monitoring.

*IPI is pending FDA 510(k) clearance

About Oridion

Oridion Systems Ltd. (http://www.oridion.com) is a global medical device company specializing in patient safety monitoring. The Company operates through wholly owned subsidiaries in the United States, Europe, and Israel.

Oridion develops proprietary medical devices and patient interfaces, based on its patented Microstream(R) technologies, for the enhancement of patient safety through the monitoring of the carbon dioxide (CO2) in a patient's breath. These products provide effective, proven airway management and are used in various clinical environments, including procedural sedation, pain management, operating rooms, critical care units, post-anesthesia care units, emergency medical services, transport, alternate care and other settings where patients' ventilation may be compromised and at risk.

    For further Oridion information please contact:

    Gerry Feldman, President,
    Walter Tabachnik, Chief Financial Officer,
    Elena Gerberg, Investor Relations,
    e-mail: investor@oridion.com
    website:http://www.oridion.com
    phone: +972-2-589-9159,
    address: Oridion Systems Ltd., P.O. Box 45025, 91450 Jerusalem, Israel.



'/>"/>
SOURCE Oridion Systems Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Oridion Signs Agreement With Major US Health Plan Provider for Microstream(R) Capnography
2. Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare
3. Oridion Wins 2008 Manufacturers Partnership Award From Independent Medical Distributors Association
4. Oridion Launches its Fully Integrated Remote Monitoring System and SARA Software for Improved Patient Safety
5. Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology
6. Nile Therapeutics Announces Positive Results from Phase 1b Safety and Pharmacodynamics Study of CD-NP in Patients with Heart Failure
7. Omeros Announces Results from a Phase 1 Study of OMS201 for Use During Urological Surgery
8. Environmental Tectonics Corporation Announces Placement of Two Monoplace Chambers at St. John Wound Center; First Computer-controlled Hyperbaric Chambers in Oklahoma
9. Genomic Health Announces Appointment of Ginger Graham to Board of Directors
10. Human Genome Sciences Announces Albuferon(R) Meets Primary Endpoint in Phase 3 Trial in Chronic Hepatitis C
11. Elsevier Announces Winners of 3rd Annual Scopus Young Indian Scientist Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... WEDI, the nation’s leading authority ... announced that Charles W. Stellar has been named by the WEDI Board of Directors ... 2016. As an executive leader with more than 35 years of experience in healthcare, ...
(Date:5/25/2016)... ... May 25, 2016 , ... Biohaven Pharmaceutical Holding Company ... granted the company’s orphan drug designation request covering BHV-4157 for the treatment of ... the FDA. , Spinocerebellar ataxia is a rare, debilitating neurodegenerative disorder that ...
(Date:5/24/2016)... Israel , May 24, 2016   MedyMatch Technology ... physicians with artificial intelligence, real-time decision support tools in the ... present at the 2016 Israeli Advanced Technology Industries (IATI) BioMed ... Israel,s 15th National Life Sciences and ... at the David Intercontinental Hotel in Tel Aviv, ...
(Date:5/24/2016)... ... May 24, 2016 , ... Media Cybernetics, ... new Media Cybernetics corporate branding reflects a results-driven revitalization for a company with ... The re-branding components include a crisp, refreshed logo and a new web presence. ...
Breaking Biology Technology:
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/22/2016)... PROVO and SANDY, Utah ... (NSO), which operates the highest sample volume laboratory in ... Tute Genomics and UNIConnect, leaders in clinical sequencing informatics ... the launch of a project to establish the informatics ... NSO has been contracted by the ...
Breaking Biology News(10 mins):